A patient with refractory hypertension – is it really Cushing syndrome?

  • Marvin Wei Jie Chua
    Corresponding Author: Dr. Marvin Wei Jie Chua, Endocrinology Service, Department of General Medicine, Sengkang General Hospital, 110 Sengkang East Way, Singapore 544886, Singapore
    Endocrinology Service, Department of General Medicine, Sengkang General Hospital
    Search for articles by this author
Published:September 01, 2022DOI:
      The patient is a 71 year old male with no past medical history who was admitted for back pain. Investigations confirmed spondylodiscitis of the L4 and L5 vertebrae with methicillin-resistant Staphylococcus Aureus (MRSA) bacteremia. He was started on intravenous (IV) vancomycin and underwent posterior L4 – L5 decompression, following which he was started on oral rifampicin in November 2020, to be continued for one year.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Agrawal A.
        • et al.
        Rifampicin and anti-hypertensive drugs in chronic kidney disease: Pharmacokinetic interactions and their clinical impact.
        Indian J. Nephrol. 2016; 26: 322-328
        • Hassani-Nezhad-Gashti F.
        • et al.
        Pregnane X Receptor Activator Rifampin Increases Blood Pressure and Stimulates Plasma Renin Activity.
        Clin. Pharmacol. Ther. 2020; 108: 856-865
        • Lee S.L.
        • et al.
        Resistant hypertension during antituberculosis treatment: how is rifampicin implicated?.
        Med. J. Malaysia. 2020; 75: 591-593